검색
Tectonic Therapeutic Inc
TECX관심 목록에 추가
24.120USD
-0.860-3.44%
종가 09-24 16:00（ET）
455.14M시가총액
손실P/E TTM
Tectonic Therapeutic Inc 정보 회사
Tectonic Therapeutic, Inc. is a biotechnology company. The Company is focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). Leveraging its technology platform called GEODe (GPCRs Engineered for Optimal Discovery), the Company is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. The Company’s lead asset, TX000045 (TX45), is a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone relaxin. TX45 is being evaluated in Phase Ia/Ib clinical trials as a potential treatment for Group 2 Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (HFpEF). TX002100 (TX2100) is its second development candidate for the treatment of Hereditary Hemorrhagic Telangiectasia (HHT).
Tectonic Therapeutic Inc 프로필
종목 코드 TECX
회사 이름Tectonic Therapeutic Inc
상장일Jun 21, 2018
CEOReicin (Alise S)
직원 수51
유형Ordinary Share
회계 연도 종료Jun 21
주소490 Arsenal Way
도시WATERTOWN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02472
전화13396663320
웹사이트https://tectonictx.com/
종목 코드 TECX
상장일Jun 21, 2018
CEOReicin (Alise S)
Tectonic Therapeutic Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Alise S. Reicin, M.D.
Dr. Alise S. Reicin, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
390.13K
-0.24%
Dr. Alise S. Reicin, M.D.
Dr. Alise S. Reicin, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
390.13K
-0.24%
Dr. Alise S. Reicin, M.D.
Dr. Alise S. Reicin, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
390.13K
-0.24%
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Chief Medical Officer
Chief Medical Officer
50.39K
-2.11%
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Chief Medical Officer
Chief Medical Officer
50.39K
-2.11%
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Chief Medical Officer
Chief Medical Officer
50.39K
-2.11%
Dr. Peter McNamara, Ph.D.
Dr. Peter McNamara, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
45.49K
--
Dr. Peter McNamara, Ph.D.
Dr. Peter McNamara, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
45.49K
--
Dr. Peter McNamara, Ph.D.
Dr. Peter McNamara, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
45.49K
--
Dr. Praveen P. Tipirneni, M.D.
Dr. Praveen P. Tipirneni, M.D.
Independent Director
Independent Director
3.04K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Alise S. Reicin, M.D.
Dr. Alise S. Reicin, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
390.13K
-0.24%
Dr. Alise S. Reicin, M.D.
Dr. Alise S. Reicin, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
390.13K
-0.24%
Dr. Alise S. Reicin, M.D.
Dr. Alise S. Reicin, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
390.13K
-0.24%
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Chief Medical Officer
Chief Medical Officer
50.39K
-2.11%
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Chief Medical Officer
Chief Medical Officer
50.39K
-2.11%
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Dr. Marcella Kuhlman (Marcie) Ruddy, M.D.
Chief Medical Officer
Chief Medical Officer
50.39K
-2.11%
자주 묻는 질문
Tectonic Therapeutic Inc의 상위 5대 주주는 누구인가요?
Tectonic Therapeutic Inc의 상위 5대 주주는 다음과 같습니다: Dr. Alise S. Reicin, M.D.
Tectonic Therapeutic Inc(TECX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Tectonic Therapeutic Inc의 주식을 보유한 기관은 총 241곳이며, 이들이 보유한 주식의 총 가치는 약 15.80M로 전체 발행 주식의 83.74%를 차지합니다. 이는 2025Q4 대비 -2940037.00 증가한 수치입니다.